Başlık:
Health economics : fundamentals and flow of funds
Yazar:
Getzen, Thomas E.
ISBN:
9780471586487
Ek Yazar:
Yayım Bilgisi:
New York : John Wiley & Sons, ©1997.
Fiziksel Tanım:
xii, 467 pages : illustrations ; 26 cm
Contents:
Terms of Trade: The Flow of Funds Through the Health Care System -- What is Economics? -- Terms of Trade -- Value -- The Flow of Funds -- Health Care Spending in the United States -- Sources of Funds -- Health Care Providers: The Uses of Funds -- Quality -- Public or Private Choices -- Research -- Time -- The Structure of the Economy: Contracts -- Economic Principles as Conceptual Tools -- Trade -- Choice: Are Benefits Greater Than Costs? -- Opportunity Cost -- Scarcity (Budget Constraints) -- Maximization/Marginalism -- Money Flows in a Circle -- Contracts and Organization -- Health Principles -- Health Is Priceless -- And Yet, Money Still Determines Health -- Health Risks Are More Public Than Private -- Individual Choices: Lifestyle Is More Than Medicine -- Measurable Differences in Quality Over Time, or Regions, Are Greater Than Most Differences in Choices Faced by Patients -- Health and the Economy -- Demand -- Need Versus Demand -- The Demand Curve -- The Diamonds-Water Paradox: An Example of Marginal Analysis -- Ceteris Paribus -- Derived Demand -- Individual, Firm, and Market Demand Curves -- Marginal Revenue -- Price Sensitivity -- Price Elasticity and Marginal Revenue -- Price Discrimination -- Is Price the Only Thing That Matters? -- Profit-Maximizing Firms, Supply, and Markets -- Efficiency -- Cost-Benefit and Cost-Effectiveness Analysis -- Cost-Benefit Analysis is About Making Choices -- An Everyday Example: Knee Injury -- Opportunity Cost: Looking at Alternatives -- Expected Value.
Electronic Access:
Table of contents http://catdir.loc.gov/catdir/toc/onix03/96021162.htmlContributor biographical information http://catdir.loc.gov/catdir/enhancements/fy0607/96021162-b.html
Publisher description http://catdir.loc.gov/catdir/description/wiley033/96021162.html
Mevcut:*
Library | Materyal Türü | Barkod | Yer Numarası | Durum |
|---|---|---|---|---|
Searching... Pamukkale Merkez Kütüphanesi | Kitap | 0103922 | W74 G48 1997 | Searching... Unknown |
Bound With These Titles
On Order
Özet
Özet
This examination of the economic analysis of medical markets and the production of health traces the economic rationale and development of the medical care organization. It examines transactions between patients and health care providers to see how profits are made, costs covered, contracts written and regulations formed. It also uses a macroeconomic perspective to explore the dynamics of change within the health care system and to consider determinants of national health spending and the role of governments in public and private health.
Author Notes
Thomas E. Getzen Temple University
Table of Contents
| Preface | p. xviii |
| Acknowledgements | p. xxi |
| About the Author | p. xxii |
| Foreword | p. xxiii |
| 1 Terms of Trade: The Flow of Funds Through the Health Care System | p. 1 |
| 1.1 What is Economics? | p. 2 |
| Terms of Trade | p. 3 |
| Value | p. 4 |
| 1.2 The Flow of Funds | p. 4 |
| Health Care Spending in the United States | p. 5 |
| Sources of Funds | p. 6 |
| Health Care Providers: The Uses of Funds | p. 8 |
| 1.3 Quality | p. 10 |
| 1.4 Public or Private Choices | p. 10 |
| 1.5 Research | p. 11 |
| 1.6 Time | p. 12 |
| 1.7 The Structure of the Economy: Contracts | p. 13 |
| 1.8 Economic Principles as Conceptual Tools | p. 14 |
| Trade | p. 14 |
| Choice: Are Benefits Greater Than Costs? | p. 14 |
| Opportunity Cost | p. 14 |
| Scarcity (Budget Constraints) | p. 14 |
| Maximization/Marginalism | p. 15 |
| Money Flows in a Circle | p. 15 |
| Contracts and Organization | p. 15 |
| 1.9 Health Principles | p. 15 |
| Health Is Priceless | p. 16 |
| And Yet, Money Still Determines Health | p. 16 |
| Health Risks Are More Public Than Private | p. 16 |
| Individual Choices: Lifestyle Is More Than Medicine | p. 16 |
| Measurable Differences in Quality Over Time, or Regions, Are Greater Than Most Differences in Choices Faced by Patients | p. 17 |
| 1.10 Health and the Economy | p. 17 |
| Suggestions for Further Reading | p. 18 |
| Summary | p. 18 |
| Problems | p. 19 |
| Endnotes | p. 20 |
| 2 Demand | p. 21 |
| 2.1 Need Versus Demand | p. 21 |
| 2.2 The Demand Curve | p. 22 |
| The Diamonds-Water Paradox: An Example of Marginal Analysis | p. 23 |
| Ceteris Paribus | p. 25 |
| Derived Demand | p. 25 |
| Individual, Firm, and Market Demand Curves | p. 26 |
| 2.3 Marginal Revenue | p. 26 |
| Price Sensitivity | p. 27 |
| Price Elasticity and Marginal Revenue | p. 28 |
| Price Discrimination | p. 30 |
| 2.4 Is Price the Only Thing That Matters? | p. 31 |
| 2.5 Profit-Maximizing Firms, Supply, and Markets | p. 32 |
| 2.6 Efficiency | p. 33 |
| Suggestions for Further Reading | p. 34 |
| Summary | p. 34 |
| Problems | p. 36 |
| Endnotes | p. 38 |
| 3 Cost-Benefit and Cost-Effectiveness Analysis | p. 39 |
| 3.1 Cost-Benefit Analysis is About Making Choices | p. 40 |
| An Everyday Example: Knee Injury | p. 40 |
| Opportunity Cost: Looking at Alternatives | p. 43 |
| Expected Value | p. 44 |
| Maximization: Finding the Optimum | p. 44 |
| Average, Total, and Marginal Costs | p. 47 |
| 3.2 An Example of Marginal Analysis: Costs and Benefits of a Sixth Stool Guaiac | p. 48 |
| 3.3 Measuring Benefits | p. 52 |
| Health | p. 52 |
| Productivity | p. 53 |
| Reductions in Future Medical Costs | p. 53 |
| 3.4 Measuring Costs | p. 53 |
| Medical Care and Administration: Charges Versus Costs | p. 54 |
| Follow-up and Treatment | p. 54 |
| Time and Pain of Patient and Family | p. 54 |
| Provider Time and Inconvenience | p. 55 |
| 3.5 The Value of Life | p. 55 |
| 3.6 Quality-Adjusted Life Years (QALYs) | p. 57 |
| Discounting Over Time | p. 57 |
| QALY League Tables | p. 58 |
| 3.7 Perspectives: Patient, Payer, Government, Provider, Society | p. 59 |
| Distribution: Whose Costs and Whose Benefits? | p. 60 |
| CBA Is a Limited Perspective | p. 60 |
| CBA and Public Policy Decision Making | p. 61 |
| Suggestions for Further Reading | p. 61 |
| Summary | p. 62 |
| Problems | p. 63 |
| Endnotes | p. 65 |
| 4 Insurance | p. 67 |
| 4.1 Methods for Covering Risks | p. 67 |
| Savings | p. 68 |
| Family and Friends | p. 68 |
| Charity | p. 68 |
| Private Market Insurance Contracts | p. 69 |
| Social Insurance | p. 70 |
| Strengths and Weaknesses of Different Forms of Risk Spreading | p. 70 |
| 4.2 Why Third-Party Payment? | p. 71 |
| Variability | p. 72 |
| 4.3 Risk Aversion | p. 74 |
| 4.4 Adverse Selection | p. 75 |
| 4.5 Moral Hazard | p. 77 |
| Welfare Losses Due to Moral Hazard | p. 78 |
| 4.6 Open or Closed Funding? | p. 80 |
| Suggestions for Further Reading | p. 81 |
| Summary | p. 81 |
| Problems | p. 82 |
| Endnotes | p. 84 |
| 5 Insurance Contracts and Managed Care | p. 86 |
| 5.1 Third-Party Transactions | p. 86 |
| Tax Benefits | p. 87 |
| Who Pays? How Much? | p. 88 |
| 5.2 Managed Care Plans | p. 89 |
| 5.3 How are Benefits Determined? | p. 90 |
| 5.4 Types of Insurance Plans | p. 90 |
| Employer-Based Group Health Insurance | p. 90 |
| Self-Paid Private Insurance | p. 92 |
| Medicare | p. 92 |
| Medicaid | p. 92 |
| Other Government Programs and Charity | p. 92 |
| The Uninsured | p. 94 |
| State Children's Health Insurance Program | p. 95 |
| Medical Savings Accounts (MSAs) and Defined Contribution "Voucher" Plans | p. 95 |
| 5.5 A Range of Risk Bearing: Fixed Premiums, Administered Services Only, and Self-Insurance | p. 96 |
| The Underwriting Cycle | p. 97 |
| 5.6 Erisa, Taxes, and Mandated Benefits | p. 97 |
| 5.7 History of Health Insurance | p. 99 |
| 5.8 Incentives--To Patients, to Payers, and to Providers | p. 102 |
| Suggestions for Further Reading | p. 103 |
| Summary | p. 103 |
| Problems | p. 104 |
| Endnotes | p. 104 |
| 6 Physicians | p. 106 |
| 6.1 Physician Payment: How Funds Flow in | p. 106 |
| Co-pays, Assignment, and Balance Billing | p. 110 |
| Physician Payment in Managed Care Plans | p. 111 |
| Incentives: Why Differences in the Type of Payment Matter | p. 111 |
| A Progression: From Prices to Reimbursement Mechanisms | p. 112 |
| 6.2 Physician Incomes | p. 112 |
| 6.3 Physician Costs: How Funds Flow Out | p. 113 |
| Physician Practice Expenses | p. 113 |
| The Labor-Leisure Choice | p. 115 |
| The Doctor's Workshop and Unpaid Hospital Inputs | p. 116 |
| Malpractice | p. 116 |
| 6.4 The Transaction Between Doctor and Patient | p. 117 |
| Asymmetric Information | p. 117 |
| 6.5 Uncertainty | p. 118 |
| 6.6 Licensure: Quality or Profits? | p. 119 |
| How Does Licensure Increase Physician Profits? | p. 119 |
| Supply and Demand Response in Licensed Versus Unlicensed Professions | p. 120 |
| How Does Licensure Improve Quality? | p. 121 |
| A Test of the Quality Hypothesis: Strong Versus Weak Licensure | p. 122 |
| Suggestions for Further Reading | p. 123 |
| Summary | p. 123 |
| Problems | p. 124 |
| Endnotes | p. 125 |
| 7 Medical Education, Organization, and Business Practices | p. 127 |
| 7.1 Medical Education | p. 127 |
| Human Capital: Medical Education as Investment | p. 128 |
| 7.2 The Origins of Licensure and Linkage to Medical Education | p. 129 |
| AMA Controls Over Physician Supply, 1930-1965 | p. 130 |
| Breaking the Contract: The Great Medical Student Expansion of 1970-1980 | p. 132 |
| Building Pressure: Fixed Domestic Graduation Rates 1980-2002 | p. 132 |
| 7.3 Adjusting Physician Supply | p. 133 |
| The Flow of New Entrants and the Stock of Physicians | p. 133 |
| Immigration of International Medical Graduates | p. 134 |
| Growth in Non-M.D. Physicians | p. 134 |
| Balancing Supply and Incomes: Tracing the Past and Projecting the Future | p. 135 |
| 7.4 Group Practice: How Organization and Technology Affect Transactions | p. 135 |
| 7.5 Kickbacks, Self-Dealing, and Side Payments | p. 138 |
| 7.6 Price Discrimination | p. 140 |
| 7.7 Practice Variations | p. 142 |
| 7.8 Insurance, Price Competition, and the Structure of Medical Markets | p. 145 |
| Suggestions for Further Reading | p. 147 |
| Summary | p. 147 |
| Problems | p. 149 |
| Endnotes | p. 152 |
| 8 Hospitals | p. 154 |
| 8.1 From Charitable Institutions to Corporate Chains: Development of the Modern Hospital | p. 154 |
| 8.2 Revenues: The Flow of Funds into the Hospital | p. 156 |
| Sources of Revenues | p. 157 |
| 8.3 Costs: The Flow of Funds Out of the Hospital | p. 162 |
| 8.4 Financial Management and cost Shifting | p. 162 |
| 8.5 Capital Financing | p. 166 |
| 8.6 Organization: Who Controls the Hospital and for What Ends? | p. 169 |
| Suggestions for Further Reading | p. 171 |
| Summary | p. 171 |
| Problems | p. 172 |
| Endnotes | p. 173 |
| 9 Management and Regulation of Hospital Costs | p. 175 |
| 9.1 Why do Some Hospitals Cost More Than Others? | p. 175 |
| 9.2 How Management Controls Costs | p. 176 |
| Short-Run Versus Long-Run Cost Functions | p. 176 |
| Uncertainty and Budgeting | p. 178 |
| 9.3 Conflict Between Economic Theory and Accounting Measures of Per Unit Cost | p. 180 |
| Timing | p. 180 |
| Whose Costs? | p. 182 |
| 9.4 Economies of Scale | p. 183 |
| The Hospital is a Multiproduct Firm | p. 184 |
| Contracting Out | p. 184 |
| 9.5 Quality and Cost | p. 185 |
| Technology: Cutting Costs or Enhancing Quality? | p. 185 |
| Improved Efficiency May Raise Total Spending | p. 185 |
| 9.6 How do Hospitals Compete? | p. 186 |
| Competing for Patients | p. 186 |
| Competing for Physicians | p. 187 |
| Competing for Contracts | p. 187 |
| Measuring Competitive Success | p. 188 |
| Measuring the Competitiveness of Markets | p. 189 |
| 9.7 Controlling Hospital Costs Through Regulation | p. 189 |
| Suggestions for Further Reading | p. 193 |
| Summary | p. 193 |
| Problems | p. 194 |
| Endnotes | p. 196 |
| 10 Managed Care | p. 197 |
| 10.1 Why Managed Care? | p. 197 |
| Costs and Quality | p. 198 |
| Management: The Distinctive Feature of Managed Care | p. 198 |
| Contractual Reforms to Reduce Costs | p. 199 |
| Reforming the Organization to Reduce Cost | p. 200 |
| 10.2 Sources and Uses of Funds | p. 201 |
| 10.3 The Range of Managed Care Plans | p. 202 |
| Provider Networks | p. 202 |
| Gatekeeping | p. 203 |
| Capitation | p. 203 |
| Withholds | p. 205 |
| Utilization Review | p. 205 |
| 10.4 How Care is Managed: A Mental Health Example | p. 206 |
| 10.5 Individual and System Risks in Health Care | p. 208 |
| 10.6 Kaiser: The Evolution of an HMO | p. 210 |
| 10.7 Ownership and Capital Markets: Signs of Failure | p. 212 |
| GHA: A Consumer Co-op Gets Bought Out by a Franchise Chain | p. 212 |
| Corporate Advantage | p. 213 |
| U.S. Healthcare: A Profitable Growth Company | p. 214 |
| 10.8 The Enthoven "Managed Competition" Plan | p. 216 |
| 10.9 Is Managed Care the Solution to Rising Costs? | p. 217 |
| Evidence on Cost Reductions | p. 217 |
| Risk Selection | p. 217 |
| Quality of Care | p. 218 |
| Costs Reductions in IPA HMOs, PPOs, and POS Plans | p. 218 |
| Administrative Costs and Profits | p. 218 |
| One-Time Savings? | p. 219 |
| 10.10 Backlash: Are There Losers as well as Winners? | p. 219 |
| Suggestions for Further Reading | p. 220 |
| Summary | p. 220 |
| Problems | p. 222 |
| Endnotes | p. 223 |
| 11 Long-Term Care | p. 227 |
| 11.1 Development of the Long-Term Care Market | p. 228 |
| 11.2 Defining Ltc: Types of Care | p. 230 |
| 11.3 Medicaid: Nursing Homes as a Two-Part Market | p. 231 |
| 11.4 Certificate of Need: Whose Needs? | p. 234 |
| Money and Quality | p. 234 |
| Competing for Certificates of Need, Not for Patients | p. 235 |
| Evidence on the Effects of CON | p. 236 |
| 11.5 Case-Mix Reimbursement | p. 236 |
| 11.6 Substitution | p. 238 |
| 11.7 Financial Reimbursement Cycles | p. 239 |
| 11.8 Continuing Care Retirement Communities and the Wealthy Elderly | p. 241 |
| Medicare Catastrophic Coverage Act of 1988 and the Taxpayer Revolt | p. 242 |
| 11.9 The Effects of Aging on Cost and Utilization | p. 243 |
| Defining Boundaries: Is Long-Term Care "Medical"? | p. 243 |
| LTC Insurance | p. 244 |
| The Effects of Aging | p. 245 |
| Suggestions for Further Reading | p. 246 |
| Summary | p. 247 |
| Problems | p. 248 |
| Endnotes | p. 249 |
| 12 Pharmaceuticals | p. 251 |
| 12.1 How Funds Flow in | p. 252 |
| Medicare and Medicaid | p. 253 |
| Inpatient Pharmaceuticals | p. 254 |
| 12.2 Uses of Funds | p. 254 |
| Retail Pharmacies | p. 255 |
| Wholesalers | p. 256 |
| Insurance Companies and PBMs | p. 256 |
| Pharmaceutical Firms | p. 256 |
| Cost Structure | p. 258 |
| 12.3 History and Regulation of Pharmaceuticals | p. 258 |
| 12.4 Research and Development | p. 262 |
| 12.5 Pharmacoeconomics and Outcomes Research | p. 265 |
| 12.6 Industry Structure and Competition | p. 265 |
| Market Segmentation: Types of Buyers | p. 266 |
| Contractual Responses to Pharmacy Benefits Management | p. 267 |
| Value and Cost | p. 267 |
| The Role of Middlemen: Distribution Versus Marketing | p. 269 |
| Research Productivity | p. 270 |
| 12.7 Trends: Form Follows Function (and Money) | p. 271 |
| Suggestions for Further Reading | p. 272 |
| Summary | p. 273 |
| Problems | p. 273 |
| Endnotes | p. 275 |
| 13 Introduction to the Macroeconomics of Health | p. 277 |
| 13.1 What is Macro Health Economics? | p. 277 |
| 13.2 Properties of the Individual Versus Properties of the System | p. 278 |
| 13.3 Dynamics: Change Over Time | p. 279 |
| 13.4 Abstractions and Complications | p. 280 |
| 13.5 The Role of Government (Overview of Chapters 14-18) | p. 282 |
| Suggestions for Further Reading | p. 282 |
| Problems | p. 282 |
| Endnotes | p. 283 |
| 14 The Role of Government | p. 284 |
| 14.1 The Flow of Government Health Funds | p. 284 |
| 14.2 The Roles of Government | p. 285 |
| Government is Necessary, Even for Private Exchange | p. 285 |
| Efficiency of Markets Under Conditions of Perfect Competition | p. 287 |
| Government in a Mixed Economy | p. 287 |
| 14.3 Law and Order | p. 288 |
| 14.4 Public Goods and Externalities | p. 289 |
| Externalities | p. 289 |
| The Coase Theorem: Transaction Costs and Property Rights | p. 290 |
| Politicians: Entrepreneurs Who Try to Get Votes | p. 291 |
| 14.5 Market Failure | p. 291 |
| Monopoly | p. 291 |
| Paternalism | p. 293 |
| 14.6 Income Redistribution and Care of the Poor | p. 294 |
| Medicaid and Medicare: Dependency or Rights? | p. 294 |
| 14.7 How Government Works | p. 295 |
| The Voluntary Sector | p. 296 |
| Government as the Citizen's Agent | p. 296 |
| Winners and Losers | p. 298 |
| 14.8 Pros and Cons of Regulation and Competition | p. 299 |
| Suggestions for Further Reading | p. 301 |
| Summary | p. 301 |
| Problems | p. 302 |
| Endnotes | p. 303 |
| 15 Public Goods and Public Health | p. 305 |
| 15.1 Characteristics of Public Goods | p. 305 |
| Privatizing Public Goods | p. 306 |
| Social Costs Depend on the Number of People | p. 307 |
| Insurance Makes Any Good More Public | p. 307 |
| 15.2 Information | p. 308 |
| Rational Consumer Ignorance | p. 309 |
| Milk or Bread: Which is More Public? | p. 309 |
| 15.3 The Theory of Pure Public Goods | p. 310 |
| Public Goods Make Most People Better Off, But Few Happy | p. 312 |
| 15.4 Infectious Disease Externalities | p. 313 |
| Epidemics | p. 314 |
| HIV/AIDS | p. 315 |
| The Sanitary Revolution: A Moral Campaign for Public Health | p. 316 |
| Formation of the U.S. Public Health Service | p. 316 |
| 15.5 Sex, Drugs, and War: Public Health in Action | p. 317 |
| Who Counts as a Citizen? Abortion and Other Dilemmas | p. 318 |
| Addiction | p. 319 |
| War and Public Health | p. 319 |
| Suggestions for Further Reading | p. 321 |
| Summary | p. 321 |
| Problems | p. 321 |
| Endnotes | p. 322 |
| 16 Economic History, Population Growth, and Medical Care | p. 324 |
| 16.1 Economic Growth has Determined the Shape of Health Care | p. 324 |
| 16.2 Birth Rates, Death Rates, and Population Growth | p. 325 |
| 16.3 The Stone Age | p. 325 |
| 16.4 The Agricultural Age | p. 326 |
| Investment and Trade | p. 327 |
| Civilization, War, and Government | p. 327 |
| The Decline of Civilizations Leads to Population Declines | p. 328 |
| The Plague | p. 329 |
| Food Supply Determines Population | p. 329 |
| The Rise of Economics | p. 329 |
| The Malthusian Hypothesis | p. 330 |
| 16.5 The Industrial Age | p. 331 |
| Why Malthus Was Wrong | p. 331 |
| Demographic Transition | p. 332 |
| Demographic Change, Income Distribution, and the Rise of the Middle Classes | p. 334 |
| 16.6 The Information Age | p. 335 |
| 16.7 Income and Health | p. 336 |
| Income and the Value of Medical Care | p. 338 |
| 16.8 Reducing Uncertainty: The Value of Life and Economic Security | p. 339 |
| The Value of Risk Reduction | p. 339 |
| Social Security and Health Insurance | p. 339 |
| Preconditions for Changing Medical Organization | p. 340 |
| 16.9 The Rise of Medical Technology | p. 341 |
| Suggestions for Further Reading | p. 343 |
| Summary | p. 343 |
| Problems | p. 345 |
| Endnotes | p. 346 |
| 17 International Comparisons of Health and Health Expenditures | p. 349 |
| 17.1 Wide Differences Among Nations | p. 349 |
| Size of the Market | p. 351 |
| 17.2 Micro Versus Macro Allocation: Health as a National Luxury Good | p. 352 |
| 17.3 Causality: Does More Spending Improve Health? | p. 354 |
| 17.4 Low-Income Countries | p. 356 |
| Sudan | p. 357 |
| Health Care in Kenya | p. 358 |
| 17.5 Middle-Income Countries | p. 359 |
| The Health Care System of Mexico | p. 360 |
| Poland | p. 361 |
| 17.6 High-Income Countries | p. 363 |
| Costs and Cost Control | p. 363 |
| Japan | p. 365 |
| The German Health System | p. 368 |
| 17.7 International Trade in Health Care | p. 370 |
| Pharmaceuticals | p. 371 |
| Equipment | p. 371 |
| Services | p. 371 |
| People and Ideas | p. 372 |
| Suggestions for Further Reading | p. 372 |
| Summary | p. 373 |
| Problems | p. 374 |
| Endnotes | p. 374 |
| 18 Dynamics of National Health Spending | p. 376 |
| 18.1 Micro and Macro Perspectives on Spending | p. 376 |
| 18.2 The Consumption Function | p. 377 |
| The Permanent Income Hypothesis | p. 378 |
| Income Elasticity and Shared Income | p. 379 |
| 18.3 Dynamics | p. 380 |
| Permanent Income and Adjustment of Health Spending to GDP | p. 382 |
| Adjustment to Inflation | p. 383 |
| A Dynamic Model of U.S. Health Expenditures | p. 385 |
| 18.4 Government Cost Controls: Spending Gaps and the Push to Regulate | p. 386 |
| Price Controls: The "ESP" Program | p. 388 |
| The Voluntary Effort | p. 389 |
| Prospective Payment System with Diagnosis-Related Groups | p. 390 |
| Why Do People Believe Cost Controls Work? | p. 391 |
| 18.5 "Spending" is Mostly Labor | p. 391 |
| Employment | p. 392 |
| Wages | p. 394 |
| Suggestions for Further Reading | p. 396 |
| Summary | p. 396 |
| Problems | p. 397 |
| Endnotes | p. 399 |
| 19 Value for Money in the Future of Health Care | p. 401 |
| 19.1 Forcing the Question: Who Gets Healthy and Who Gets Paid? | p. 401 |
| 19.2 Spending Money or Producing Health? | p. 402 |
| 19.3 Allocation, Allocation, Allocation | p. 404 |
| 19.4 Dynamic Efficiency | p. 405 |
| 19.5 The Future | p. 406 |
| Suggestions for Further Reading | p. 407 |
| Summary | p. 408 |
| Problems | p. 408 |
| Endnotes | p. 409 |
| Glossary | p. 411 |
| Index | p. 421 |
Select a list
The following items were successfully added.
There was an error while adding the following items. Please try again.
One or more items could not be added because you are not logged in.
